Product Information

RANOLAZINE ER 500 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1609 per EA under NDC 29300029616. Its NADAC has been published 80 times since Feb 12, 2025.

FDA first approved this application on Mar 16, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RANOLAZINE ER 500 MG TABLET

Ranolazine
$0.1609per EA

Strength

500 mg/1

NDC

29300029616

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RANOLAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA213083

FDA Approved

3/16/2023

TE Code

AB

On Market Since

3/16/2023

Pharmacological Classes

Anti-anginal
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
Organic Cation Transporter 2 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for RANOLAZINE ER 500 MG TABLET has been published 80 times since Feb 12, 2025, and over the history we have for it it has declined 14.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1609 per EA
All-time high$0.2071 (Jun 11, 2025)
All-time low$0.1581 (Jul 22, 2026)
52-week high$0.1743
52-week low$0.1581
Median price$0.1679
Average price$0.1771
Largest weekly change-7.5% (Aug 20, 2025)
Weeks tracked80
Tracking sinceFeb 12, 2025

Price History

1W

+1.7%

1M

+1.7%

3M

-4.1%

6M

-0.9%

1Y

-7.7%

3Y

N/A

5Y

N/A

All

-14.2%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RANOLAZINE ER 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 500 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1609 per EA (NDC 29300029616), effective Aug 19, 2026.

How has the price of RANOLAZINE ER 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for RANOLAZINE ER 500 MG TABLET has declined 14.2%. It has been tracked across 80 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 500 MG TABLET?

Since Feb 12, 2025, the NADAC for RANOLAZINE ER 500 MG TABLET has ranged from a low of $0.1581 (Jul 22, 2026) to a high of $0.2071 (Jun 11, 2025), with a median of $0.1679 per EA.

Are there cheaper alternatives to RANOLAZINE ER 500 MG TABLET?

12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RANOLAZINE ER 500 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RANOLAZINE ER 500 MG TABLET?

RANOLAZINE ER 500 MG TABLET (NDC 29300029616) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.